¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"metabolic myopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® basal metabolic rate(BMR) ÇÑ±Û ±âÃÊ´ë»çÀ²
¼³¸í   
  Ç¥ÁØ ±âÃÊ´ë»ç·®°ú ºñ±³ÇßÀ» ¶§ °³Ã¼ ±âÃÊ´ë»ç·®ÀÌ º¸À̴ ÆíÂ÷¸¦ Ç¥½ÃÇϴ Áö¼ö. ±âÃÊ´ë»ç·®Àº »ý¸íÀ» À¯ÁöÇϴµ¥ ÇÊ¿äÇÑ ÃÖ¼ÒÇÑÀÇ ¿¡³ÊÁö ´ë»ç·®À̸ç, ¼º°ú ¿¬·ÉÀÌ µ¿ÀÏÇÑ °Ç°­ÀÎÀÇ ±âÃÊ´ë»ç·®Àº Ã¼Ç¥¸éÀû¿¡ ºñ·ÊÇÑ´Ù. À̰ÍÀ» Ã¼Ç¥¸éÀûÀÇ ¹ýÄ¢À̶ó°í Çϸç, 1882³â µ¶ÀÏÀÇ ´ë»ç»ý¸®ÇÐÀÚ M. ºê·ç³Ê¿¡ ÀÇÇØ Á¦Ã¢µÇ¾ú´Ù. Ã¼Ç¥¸éÀûÀº ½ÅÀå°ú Ã¼Áß¿¡ ÀÇÇØ »êÃâµÈ´Ù. µû¶ó¼­ ¼º-¿¬·É-½ÅÀå-üÁßÀ» ¾Ë¸é Ç¥ÁرâÃÊ·® Y°¡ »êÃâµÇ°í ½ÇÁ¦ÀÇ ±âÃÊ´ë»ç·® X´Â »ê¼Ò¼Òºñ·®°ú ÀÌ»êȭź¼Ò ¹ß»ý·®¿¡¼­ »êÃâµÈ´Ù. ±×¸®°í X¿Í YÀÇ Â÷À̸¦ Y·Î ³ª´« °ª(%)À» ±âÃÊ´ë»çÀ²À̶ó°í ÇÑ´Ù. °æÇèÀûÀ¸·Î ¾òÀº BMRÀÇ °£´ÜÇÑ ÃøÁ¤¹ýµµ ÀÖÀ¸¸ç ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇÑ´Ù. ÀÌ ½Ä¿¡¼­ ¸ÆÆøÀ̶õ ÃÖ°íÇ÷¾Ð°ú ÃÖÀúÇ÷¾ÐÀÇ Â÷¸¦ ¸»ÇÑ´Ù. BMR(%)=0.75(1ºÐ ¸Æ¹Ú¼ö + 0.74¡¿¸ÆÆø)£­72. BMRÀÌ 10% À̳»À̸é Á¤»ó¹üÀ§, +10% ÀÌ»óÀ̸頱âÃÊ´ë»çÇ×Áø, £­10% ÀÌÇÏÀ̸頱âÃÊ´ë»ç ÀúÇ϶ó°í ÇÑ´Ù. ±âÃÊ´ë»ç´Â °øº¹½Ã(½ÄÈÄ 10½Ã°£ °æ°ú)¿¡ ¾ÈÁ¤µÈ »óÅ¿¡¼­ ´ÜÀ§ ½Ã°£´ç ÀÌ¿ëµÇ´Â ¿¡³ÊÁöÀÇ ¾ç, Áï, ÇÑ ½Ã°£´ç, ¸ö Ç¥¸éÀÇ 1m2´ç ¶Ç´Â ¸ö¹«°Ô 1kg ´ç Ä®·Î¸®·Î ³ªÅ¸³½´Ù. À̰ÍÀº °³Àο¡ µû¶ó ´Ù¸£¸ç Àå±â°£¿¡´Â °ÅÀÇ º¯È­°¡ ¾øÁö¸¸ Áúº´ µîÀ¸·Î ÀÎÇØ º¯µ¿µÈ´Ù. ½ÇÃøÇÑ ±âÃÊ´ë»ç¸¦ Ç¥ÁØÄ¡¿Í ºñ±³ÇÔÀ¸·Î½á Áúº´ÀÇ Áø´Ü µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Ù BMR=(½ÇÃøÄ¡-Ç¥ÁØÄ¡)/Ç¥ÁØÄ¡ ¡¿100(%)·Î ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±Ù(À°)º´(Áõ)
  • mitochondrial myopathy
    »ç¸³Ã¼±Ù(À°)º´(Áõ)
  • myopathy
    ±Ù(À°)º´(Áõ)
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • cerebral metabolic rate
    ³ú´ë»çÀ²
  • energy metabolic rate
    ¿¡³ÊÁö´ë»çÀ²
  • metabolic
    ´ë»ç-
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • metabolic acidemia
    ´ë»ç»êÇ÷Áõ
  • metabolic acidosis
    ´ë»ç»êÁõ
  • metabolic alkalemia
    ´ë»ç¾ËÄ®¸®Ç÷Áõ
  • metabolic alkalosis
    ´ë»ç¾ËÄ®¸®Áõ
  • metabolic antigen
    ´ë»çÇ׿ø
  • metabolic coma
    ´ë»ç¼ºÈ¥¼ö
  • metabolic cycle
    ´ë»çÁÖ±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myopathy
    ±ÙÀ°º´Áõ
  • metabolic acidosis
    ´ë»ç»êÁõ
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • metabolic
    ´ë»ç-
  • metabolic pathway
    ´ë»ç°æ·Î
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • metabolic turnover
    ´ë»çÀüȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±ÙÀ°º´Áõ
  • myopathy
    ±ÙÀ°º´Áõ
  • mitochondrial myopathy
    »ç¸³Ã¼±ÙÀ°º´Áõ
  • metabolic abnormality
    ´ë»çÀÌ»ó
  • metabolic acidemia
    ´ë»ç»êÇ÷Áõ
  • metabolic acidosis
    ´ë»ç»êÁõ
  • metabolic alkalemia
    ´ë»ç¾ËÄ«¸®Ç÷Áõ
  • metabolic alkalosis
    ´ë»ç¾ËÄ®¸®Áõ
  • metabolic antigen
    ´ë»çÇ׿ø
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • cerebral metabolic rate
    ³ú´ë»çÀ²
  • metabolic cycle
    ´ë»çÁÖ±â
  • metabolic detoxification
    ´ë»çÇØµ¶
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • BMR=£¾basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • porphyrin metabolic disorder
    Æ÷¸£ÇǸ°´ë»çÀå¾Ö
  • relative metabolic rate
    »ó´ëÀû ´ë»çÀ².
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • alcoholic myopathy
    ¾ËÄڿüº ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • alcoholic myopathy
    ¾ËÄڿüº ±Ùº´Áõ(¡­àõ ÐÉÜ»ñø)
  • cardiac myopathy
    ½É(Àå)±ÙÁõ(ãýÐÉñø)
  • cardioskeletal myopathy
  • centronuclear myopathy
    Áß½ÉÇÙ¼º±Ùº´Áõ(¡­ú·àõÐÉÜ»ñø)
  • chloroquine myopathy
    Ŭ·Î·ÎŲ ±Ùº´Áõ(¡­ÐÉÜ»ñø)
  • congental myopathy
  • cortisone myopathy
    ÄÚ¸£Æ¼¼Õ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • distal myopathy
    ¿øÀ§¼º ±Ùº´Áõ.
  • lipid myopathy
    Áö¹æ±Ùº´Áõ(¡­ÐÉÜ»ñø)
  • myopathy
    ±Ùº´Áõ(ÐÉÜ»ñø).
  • myopathy
    ±Ùº´Áõ
  • myopathy distal
    ¿øÀ§ºÎ±Ùº´Áõ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Metabolic defect of minerals (Asiderosis)
    ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
    [¿¾ ¿ë¾î] ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
  • Metabolic defect of pigment (Methemoglobinemia)
    »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
    [¿¾ ¿ë¾î] »ö¼Ò´ë»ç°áÇÔ(¸ÞÆ®Çì¸ð±×·ÎºóÇ÷Áõ)
  • Congenital metabolic defect
    ¼±Ãµ´ë»ç°áÇÔ
    [¿¾ ¿ë¾î] ¼±Ãµ¼º´ë»ç¼º°áÇÔ
  • Metabolic defect of steroid (Adrenogenital syndrome)
    ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
    [¿¾ ¿ë¾î] ½ºÅ×·ÎÀ̵å´ë»ç°áÇÔ(ºÎ½Å»ý½Ä±âÁõÈıº)
  • Metabolic defect of amino acid (Alkaptonuria)
    ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
    [¿¾ ¿ë¾î] ¾Æ¹Ì³ë»ê´ë»ç°áÇÔ(¾Ëİſ´¢Áõ)
  • Metabolic defect of carbohydrate (Galactosemia)
    ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
    [¿¾ ¿ë¾î] ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
  • Metabolic defect of nucleic acid (Purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
    [¿¾ ¿ë¾î] ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic antigen
    ´ë»çÇ׿ø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basal metabolic rate
    "±â(ÃÊ,º»)´ë»çÀ²(Ðñ(õ¨,Üâ)ÓÛÞóëÒ)"
  • branched metabolic pathway
    ºÐÁö´ë»ç°æ·Î(ÝÂò«ÓÛÞóÌèÖØ)
  • central metabolic pathway
    ÁßÃß´ë»ç°æ·Î(ñéõÒÓÛÞóÌèÖØ)
  • cyclic metabolic pathway
    ȸ·Î ´ë»ç°æ·Î(üÞÖØÓÛÞóÌèÖØ)
  • hyperchloremic metabolic acidosis
    °ú(Φ)¿°¼ÒÇ÷(ç¤áÈúì) ´ë»ç»êÁõ(ÓÛÞóß«ñø)
  • layered metabolic pathway
    Ãþ´ë»ç°æ·Î(öµÓÛÞóÌèÖØ)
  • linear metabolic pathway
    ¼±Çü ´ë»ç°æ·Î(àÊû¡ÓÛÞóÌèÖØ)
  • metabolic acidosis
    ´ë»ç¼º»êÁõ(ÓÛÞóàõß«ñø)
  • metabolic alkalosis
    ´ë»ç¼º(ÓÛÞóàõ)¾ËÄ«¸®Áõ(ñø)
  • metabolic antagonist
    ´ë»ç¼º ±æÇ×Á¦(ÓÛÞóàõÑÏùòð¥))
  • metabolic balance
    ´ë»ç ±ÕÇü(ÓÛÞóгû¬)
  • metabolic block
    ´ë»ç Â÷´Ü(ÓÛÞóó´Ó¨)
  • metabolic bypass
    ´ë»ç Ãø·Î(ÓÛÞóö°ÖØ)
  • metabolic depression
    ´ë»ç ¾ï¾Ð(ÓÛÞóåääâ)
  • metabolic disease
    ´ë»çÁúȯ(ÓÛÞóòðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • metabolic
    ´ë»ç¼ºÀÇ
  • metabolic acidosis
    ´ë»ç¼º»êÁõ, ´ë»ç¼º¾Æ½Ãµµ½Ã½º
  • metabolic alkalosis
    ´ë»ç¼º¾ËÄ®¸®Áõ
  • metabolic disease
    ´ë»ç¼ºÁúȯ
  • metabolic disorder
    ´ë»çÀå¾Ö
  • metabolic rate
    ´ë»çÀ²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCM Hypertrophic Cardio-Myopathy
  = HCMP
LIMM lethal infantile mitochondrial myopathy
MTM Thayer-Martin, modified [agar]; myotubular myopathy
MTMX myotubular myopathy, X-linked
XLMTM X-linked myotubular myopathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CNM Centronuclear myopathy
MM Miyoshi myopathy
MTM1 Myotubular myopathy
PROMM Proximal myotonic myopathy
IIM idiopathic inflammatory myopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ
  • centronuclear myopathy
    Áß½ÉÇÙ ±Ùº´Áõ
    Áß¾Ó¿¡ ÇÙÀÌ ÀÖ´Â ±Ù¼¶À¯°¡ ÅÂ¾Æ ±Ù¼¶À¯ÀÇ Æ¯Â¡ÀÎ ±Ù¼¼°ü
  • chloroquine myopathy
    Ŭ·Î·ÎŲ ±Ùº´Áõ
  • fingerprint body myopathy
    Áö¹® ¼Òü ±Ùº´Áõ
    ´ë´ÜÈ÷ µå¹® ÁúȯÀ¸·Î À¯¾Æ±âºÎÅÍÀÇ Àü½ÅÀû ±Ù ¼è¾à, À§Ãà, Àú±äÀåµµ¿Í Áö´É ÀúÇϰ¡ ³ªÅ¸³­´Ù. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ÀÛÀº À§ÃàµÈ ¼¶À¯¸¦ º¼ ¼ö ÀÖÀ¸¸ç ÀüÀÚÇö¹Ì°æ»ó¿¡¼­ ±Ù ¼¶À¯ÀÇ ¸·°ú ¼öÃà ¹°Áú »çÀÌ¿¡ ƯÀÌÇÑ ºÀÀÔü¸¦ º¸À̴µ¥ ÀÌ ºÀÀÔü´Â ¸·À¸·Î ½ÎÀÌÁö ¾Ê°í º¹ÀâÇÑ ÃþÆÇ ¹è¿­ÀÌ ¸¶Ä¡ Áö¹®°°ÀÌ º¸À̰í ÀÌ·¯ÇÑ ÃþÆÇµéÀº Åé´Ï °°Àº µ¹ÃâÀ» °®°í ÀÖ´Ù.
  • myotubular myopathy
    ±Ù ¼¼°ü¼º ±ÙÁõ
    ¼±Ãµ¼º ºñÁøÇ༺ ±Ù Àå¾Ö·Î ±Ù ¼¶À¯ÀÇ Á߽ɿ¡ ÀåÃàÀ» µû¶ó¼­ ÀÏ·Ä·Î ¹è¿­ÇÏ´Â Á᫐ ÇÙÀÌ ´ë´Ù¼öÀÇ ±Ù ¼¶À¯¿¡ ÀÎÁ¤µÇ´Â °ÍÀÌ Æ¯Â¡À¸·Î Å»ý±âÀÇ ±Ù°ü°ú À¯»çÇÑ Á¡¿¡¼­ ¸í¸íµÇ¾ú´Ù. Á᫐ ÇÙ ÁÖº¯¿¡ ±Ù¿ø¼¶À¯°¡ °á¿©µÈ ºÎºÐÀÌ ÀÖ´Â °æ¿ìµµ ÀÖ´Ù. ±Ù ±äÀå ÀúÇÏ, ¿îµ¿ ¹ß´ÞÀÇ Áö¿¬, ±Ù·Â ÀúÇÏ, ¾È°Ë Çϼö, ¾È¸é±Ù, ¿Ü¾È±Ù, °æ±Ù µîµµ ħ¹üµÈ´Ù. Ç÷û CPK´Â Á¤»óÀ̰ųª °æµµÀÇ »ó½ÂÀ» ³ªÅ¸³½´Ù.
  • nemaline myopathy
    ³×¸»¸°, °£¼Òü
  • basal metabolic rate
    ±âÃÊ ´ë»çÀ²
    ½Ä»ç ÈÄ ÀÏÁ¤ ½Ã°£ÀÌ Áö³ª°í ³ª¼­ÀÇ ¾ÈÁ¤ »óÅ¿¡¼­ÀÇ »ê¼Ò ¼Òºñ ¼Óµµ.
  • metabolic
    ´ë»ç¼ºÀÇ
  • metabolic acidosis
    ´ë»ç¼º »êÁõ, ´ë»ç¼º ¾Æ½Ãµµ½Ã½º
    ÁÖ¿ä ÁöÇ¥´Â È£Èí¼º ¾ËÄ®¸®Áõ¿¡¼­ º¸´Â ¹Ù¿Í °°ÀÌ Áßź»ê ÀÌ¿ÂÀÇ °¨¼ÒÀÌ´Ù. ±×·¯³ª ÀÌ µÎ Àå¾ÖÀÇ »êµµ´Â ´Ù¸£´Ù. ´ë»ç¼º »êÁõÀÇ ¿øÀÎÀº À½ À̿ Â÷À̸¦ °è»êÇÏ´Â °ÍÀÌ À¯¿ëÇÏ´Ù. Áõ»óÀº ÁÖ·Î ±âÁ¸ ÁúȯÀÇ Áõ»óÀÌ´Ù. º¸»óÀû °úȯ±â´Â Áß¿äÇÑ ÀÓ»óÀû ¡ÈÄÀÌ°í ¿ø¹ß¼º È£ÈíÀå¾Ö·Î À߸ø ÇØ¼®µÇ¾î Áú ¼ö ÀÖ´Ù.
  • metabolic alkalosis
    ´ë»ç¼º ¾ËÄ®¸®Áõ, ´ë»ç¼º ¾ËÄ®·Î½Ã½º
    ½ÅüÀÇ »ê-¿°±â ÆòÇüÀÌ ¾ËÄ®¸®ÀÇ ÃàÀû ¶Ç´Â ºñź»ê °íÁ¤, »êÀÇ »ó½Ç¿¡ ÀÇÇÏ¿© ¾ËÄ®¸® ÃøÀ¸·Î ÀÌÇàµÇ´Â Àå¾Ö.
  • metabolic antagonist
    ´ë»ç ±æÇ×Á¦
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metabolic defect of pigment
    »ö¼Ò ´ë»ç °áÇÔ
  • metabolic disease
    ´ë»ç¼º Áúȯ
    ½Åü ¼¼Æ÷ÀÇ È­ÇйÝÀÀÀÇ Àå¾Ö°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
carcinomatous myopathy <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness.
(27 Sep 1997)
centronuclear myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
rod myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
myopathy <neurology> Any disease of a muscle.
Origin: Gr. Pathos = disease
(18 Nov 1997)
myotubular myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
nemaline myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
ocular myopathy A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
thyrotoxic myopathy Extreme muscular weakness in severe thyrotoxicosis affecting muscles of limbs and trunk as well as those used in speech and swallowing.
(05 Mar 2000)
basal metabolic rate <biochemistry, biology> The metabolic rate as measured under basal conditions: 12 hours after eating, after a restful sleep, no exercise or activity preceding test, elimination of emotional excitement and occurring in a comfortable temperature.
Acronym: BMR
(15 Nov 1997)
brain diseases, metabolic Metabolic disorders which lead to pathological changes and/or functional deviations of the brain.
(12 Dec 1998)
rate, basal metabolic A measure of the rate of metabolism. For example, someone with an overly active thyroid will have an elevated basal metabolic rate.
(12 Dec 1998)
metabolic 1. <biology> Of or pertaining to metamorphosis; pertaining to, or involving, change.
2. <physiology> Of or pertaining to metabolism; as, metabolic activity; metabolic force.
Source: Websters Dictionary
(01 Mar 1998)
metabolic acidosis <biochemistry> A metabolic derangement of acid-base balance where the blood pH is abnormally low.
Causes include haemorrhagic shock, cardiogenic shock, severe dehydration, sepsis, toxic ingestion (for example isopropyl alcohol, methanol), alcoholic ketoacidosis, lactic acidosis, renal failure and diabetic ketoacidosis.
Respiratory acidosis will occur if the lungs are not ventilating properly.
(27 Jun 1999)
metabolic alkalosis <biochemistry> A metabolic derangement where the pH of the blood is abnormally high (basic).
This condition may result from hyperventilation, the use of a particular drug, excessive vomiting or dehydration (contraction alkalosis).
(27 Jun 1999)
metabolic burst <biochemistry> Response of phagocytes to particles (particularly if opsonise d) and to agonists such as formyl peptides and phorbol esters, an enhanced uptake of oxygen leads to the production, by an NADH dependent system, of hydrogen peroxide, superoxide anions and hydroxyl radicals, all of which play a part in bactericidal activity.
Defects in the metabolic burst, as in chronic granulomatous disease, predispose to infection particularly with catalase positive bacteria and are usually fatal in childhood.
(27 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • metabolic
    (½ÅÁø)´ë»çÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á